Ticker
ABUSCompany Name
ARBUTUS BIOPHARMA CORPSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Operating Income |
---|---|
6/30/2025 | $ -56.79M |
3/31/2025 | $ -79.91M |
12/31/2024 | $ -73.69M |
9/30/2024 | $ -82.17M |
6/30/2024 | $ -82.43M |
3/31/2024 | $ -80.08M |
12/31/2023 | $ -78.03M |
9/30/2023 | $ -78.47M |
6/30/2023 | $ -74.71M |
3/31/2023 | $ -69.59M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Minimum
Jun 30, 2024
Maximum
Sep 30, 2020
Average
Median
filtered constituents | 3.32K |
---|---|
min | $ -410.64M |
max | $ 444.54M |
average | $ 26.31M |
median | $ -903K |
std | $ 130.88M |